Ferric carboxymaltose is an intravenous iron replacement therapy primarily used to treat iron deficiency anemia. It is prescribed when oral iron supplements are ineffective, not tolerated, or when a rapid iron build-up is required.
Primary Uses
- Iron Deficiency Anemia: Treats anemia in adults and children (where indicated) resulting from causes like chronic kidney disease (non-dialysis-dependent), inflammatory bowel disease, heavy uterine bleeding, or postpartum recovery.
- Heart Failure: Improves exercise capacity and quality of life in specific adult patients with symptomatic heart failure who are also iron deficient.
